Study on the Effectiveness and Safety of norethisterone Acetate controlled release tablet in management of abnormal uterine bleeding
Not Applicable
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2024/07/070268
- Lead Sponsor
- Torrent Pharmaceuticals Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Female patient with more than 18 years with abnormal uterine bleeding.
2. Patients who were treated with Norethisterone acetate-controlled release tablets.
Exclusion Criteria
1. Contraindications to any ingredient present
2. Any other factor or condition as per the discretion of treating physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method